ARYA Sciences Acquisition Corp IV
ARYD · NASDAQ
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $612 | $2,745 | $960 | $79 |
| SG&A Expenses | $612 | $2,745 | $960 | $79 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $612 | $2,745 | $960 | $79 |
| Operating Income | -$612 | -$2,745 | -$960 | -$79 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $366 | $525 | $505 | $460 |
| Pre-Tax Income | -$246 | -$2,220 | -$455 | $382 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$246 | -$2,220 | -$455 | $382 |
| % Margin | – | – | – | – |
| EPS | -0.032 | -0.28 | -0.061 | 0.051 |
| % Growth | 88.7% | -356.8% | -219.3% | – |
| EPS Diluted | -0.032 | -0.28 | -0.061 | 0.051 |
| Weighted Avg Shares Out | 7,784 | 7,927 | 7,428 | 7,428 |
| Weighted Avg Shares Out Dil | 7,784 | 7,927 | 7,428 | 7,428 |
| Supplemental Information | – | – | – | – |
| Interest Income | $512 | $525 | $505 | $460 |
| Interest Expense | $0 | $1,129 | $0 | $0 |
| Depreciation & Amortization | $612 | $1,128 | $960 | $79 |
| EBITDA | -$612 | $38 | -$960 | -$79 |
| % Margin | – | – | – | – |